ContractSublease • May 11th, 2021 • Aileron Therapeutics Inc • Pharmaceutical preparations • New York
DocuSign Envelope ID: 7B2CF802-FA2C-4771-BA88-9E593E041528 Execution Version SUBLEASE This Sublease (this “Sublease”) is entered into as of this 26th day of March, 2021, by and among Vittoria Industries North America, Inc., a Delaware corporation (“Sublandlord”), Aileron Therapeutics, Inc., a Delaware corporation (“Subtenant”), and Waterfront Equity Partners, LLC, a Massachusetts limited liability company (“Prime Landlord”). INTRODUCTORY STATEMENTS A. By Lease Agreement dated as of July 13, 2012 (the “Prime Lease”), by and between Sublandlord and Prime Landlord, a true, correct and complete copy of which is attached hereto as Exhibit A, Prime Landlord leases to Sublandlord 3,365 square feet of the first floor (the “Subleased Premises”) in the building located at 285 Summer Street, Boston, Massachusetts (the “Building”), all as more particularly described in the Prime Lease. B. The Subleased Premises was previously subleased to Enevo, Inc., a Delaware corporation (“Enevo”), but Enevo ha
